Histopathological grades as prognostic factors of H3 K27-altered diffuse midline glioma and their prediction using multiparametric MR imaging
- PMID: 40478276
- DOI: 10.1007/s00234-025-03660-8
Histopathological grades as prognostic factors of H3 K27-altered diffuse midline glioma and their prediction using multiparametric MR imaging
Abstract
Background: H3K27-altered diffuse midline gliomas (H3K27-altered DMGs) are classified as WHO grade 4 tumors despite their histopathological characteristics. However, histopathological grades are known to have an important effect on prognosis. This study aims to investigate the prognostic impact of histopathological grades on H3K27-altered DMGs and to predict the grades using multiparametric MRI.
Methods: We conducted a retrospective study on H3K27-altered DMG patients diagnosed between December 2016 and February 2023. Tumors were classified as histologically lower- or high-grade DMGs by experienced pathologists. The influence of histopathological grades on prognosis was analyzed by Kaplan-Meier curve and Cox regression. Propensity score matching minimized baseline bias. Clinical and multimodal MRI variables were analyzed through age-stratified subgroup analysis. Logistic regression model was constructed for grade prediction and evaluated using the C-index and F1 score.
Results: 90 (53 lower-grade, 37 high-grade) had survival data and 44 (26 lower-grade, 18 high-grade) had complete multiparametric MRI data. Lower-grade patients exhibited significantly longer median overall survival than high-grade (10.5 months vs. 4 months, p < 0.05). Histopathological grade was confirmed as an independent prognostic factor. Qualitative MR imaging features revealed that high-grade DMGs in juveniles showed significantly larger enhancement quality and edema proportion (p < 0.05). Quantitative perfusion parameters like relative cerebral blood flow (rCBF) and relative cerebral blood volume (rCBV) differed significantly between high- and lower-grade groups in both juveniles and adults (p < 0.05). rCBF_99th, enhancement quality, and edema proportion, selected from variables with intergroup differences, formed a nomogram model with a C-index of 0.8596, AUC of 0.885 (0.833 validation), and F1 score of 0.8648.
Conclusions: Histological grades could not be ignored when assessing the prognosis of H3K27-altered DMGs. Multimodal MR imaging signatures may play an important role in the prediction of histological grades and thus contribute to a layered risk management of DMGs.
Keywords: Diffuse midline glioma, H3 K27-altered; Functional magnetic resonance imaging; Grading; High grade; Lower grade.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Human ethics and consent to participate declarations: Not applicable. Ethics approval: The research protocol was approved by the ethics commissions of the West China Hospital Ethics Committee with a waiver of informed consent. Consent to participate: Informed consent was waived due to its retrospective nature. Consent to publish: The authors affirm that human research participants provided informed consent for publication of Figure S4. Competing interests: The authors declare no potential conflicts of interest.
Similar articles
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.Acta Neuropathol. 2024 Sep 10;148(1):40. doi: 10.1007/s00401-024-02800-3. Acta Neuropathol. 2024. PMID: 39256213 Free PMC article.
-
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study.Acta Neuropathol Commun. 2025 Apr 16;13(1):77. doi: 10.1186/s40478-025-01989-y. Acta Neuropathol Commun. 2025. PMID: 40241149 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma.Acta Neuropathol Commun. 2025 Aug 23;13(1):183. doi: 10.1186/s40478-025-02101-0. Acta Neuropathol Commun. 2025. PMID: 40849656 Free PMC article.
References
-
- Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226–231 - PubMed
-
- Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neurooncology 23(8):1231–1251
-
- Solomon DA, Wood MD, Tihan T et al (2016) Diffuse Midline Gliomas with Histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathology (Zurich, Switzerland) 26(5):569–580 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical